Bora Pharmaceuticals Co., Ltd. (\u201cBora\u201d or \u201cthe Company\u201d, TWSE: 6472), a global leader in pharmaceutical manufacturing, today announced the appointment of Jean-Baptiste (\u201cJB\u201d) Agnus as Chief Commercial Officer. In this role, he will lead Bora\u2019s commercial strategy for its sterile injectables and complex small molecule offerings, as well as playing a key role in its M&A and strategic partnership initiatives.<\/p>\n\n\n\n
\u201cI am thrilled to welcome JB, who brings with him more than 25 years of biopharmaceutical industry experience. I look forward to working with him to meet the needs of our partners and the patients we serve together, and support this rapidly growing organization,\u201d commented J.D. Mowery, President of Bora\u2019s CDMO Division. \u201cWe at Bora are deeply committed to providing the highest standards of quality and customer service. JB\u2019s experience and leadership will serve us well as we implement growth and investment strategies to better serve our clients and patients worldwide.\u201d<\/p>\n\n\n\n
Agnus joins Bora Group from KBI Biopharma, where he led global business development. Prior to that, he held various senior leadership roles in business development at AGC Biologics, Ajinomoto Bio-Pharma Services, Novasep, and Isochem. He holds a bachelor\u2019s degree in organic chemistry from Universit\u00e9 Paul Sabatier Toulouse III, Toulouse, France, and a master\u2019s degree in chemical engineering from Centrale M\u00e9diterran\u00e9e, Marseille, France.<\/p>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Bora Pharmaceuticals Co., Ltd. (\u201cBora\u201d or \u201cthe Company\u201d, TWSE: 6472), a global leader in pharmaceutical manufacturing, today announced the appointment of Jean-Baptiste (\u201cJB\u201d) Agnus as Chief Commercial Officer. In this role, he will lead Bora\u2019s commercial strategy for its sterile injectables and complex small molecule offerings, as well as playing a key role in its […]<\/p>\n","protected":false},"author":29,"featured_media":987500945,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[66],"tags":[],"class_list":["post-987500944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-people"],"aioseo_notices":[],"acf":[],"_links":{"self":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987500944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/comments?post=987500944"}],"version-history":[{"count":0,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/987500944\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media\/987500945"}],"wp:attachment":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media?parent=987500944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/categories?post=987500944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/tags?post=987500944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}